Sign Out
Osteoporosis has been associated with long-term heparin treatment.
The undesirable effects are listed by system organ class and frequency: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000), not known (cannot be estimated from the available data).
The frequency of adverse events (AEs) reported with bemiparin is similar to those reported with other LMWHs and is as follows: See Table 2.
Click on icon to see table/diagram/image
View ADR Reporting Link
Continue with Google